2000
Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study
Fitzgerald P, Oshima A, Hayase M, Metz J, Bailey S, Baim D, Cleman M, Deutsch E, Diver D, Leon M, Moses J, Oesterle S, Overlie P, Pepine C, Safian R, Shani J, Simonton C, Smalling R, Teirstein P, Zidar J, Yeung A, Kuntz R, Yock P, Investigators F. Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study. Circulation 2000, 102: 523-530. PMID: 10920064, DOI: 10.1161/01.cir.102.5.523.Peer-Reviewed Original ResearchConceptsIntravascular ultrasoundQuantitative coronary ultrasoundUltrasound guidanceClinical outcomesStent implantationAngiographic guidanceCoronary ultrasoundStent deploymentLarger minimal lumen diameterStent expansionIVUS-guided groupMinimal lumen diameterQuantitative coronary angiographyMinimal stent areaRoutine ultrasound guidanceVessel revascularizationSurgical therapyCoronary angiographyClinical eventsIndex vesselStent areaRegimen studiesLumen diameterPatientsAngiography
1996
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators.
Mark D, Talley J, Topol E, Bowman L, Lam L, Anderson K, Jollis J, Cleman M, Lee K, Aversano T, Untereker W, Davidson-Ray L, Califf R. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation 1996, 94: 629-35. PMID: 8772681, DOI: 10.1161/01.cir.94.4.629.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplastyAntibodies, MonoclonalAnticoagulantsAspirinBlood TransfusionCosts and Cost AnalysisDouble-Blind MethodFemaleHeparinHumansImmunoglobulin Fab FragmentsInfusions, IntravenousInjections, IntravenousMaleMiddle AgedMyocardial IschemiaPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexRecurrenceStentsTreatment OutcomeUnited StatesConceptsHigh-risk coronary angioplastyC7E3 FabIschemic eventsCoronary angioplastyInitial hospitalizationPlatelet glycoprotein IIb/IIIa inhibitionGlycoprotein IIb/IIIa inhibitionIIb/IIIa inhibitionAggressive platelet inhibitionBaseline medical costsIschemic end pointsReduced ischemic eventsAcute ischemic eventsCost of therapyEPIC trialMajor bleedingBleeding episodesIschemic complicationsStandard carePlatelet inhibitionHospitalization ratesReceptor antibodiesHospital costsMedical costsMedicare fee
1993
Clinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success
Ilia R, Kolanski D, Setaro J, Brennan J, Cabin H, Cleman M, Remetz M. Clinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success. Angiology 1993, 44: 677-682. PMID: 8357092, DOI: 10.1177/000331979304400901.Peer-Reviewed Original ResearchConceptsCoronary angioplastyPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyAcute myocardial infarctionSuccess rateDegree of stenosisLong-term pretreatmentAngiographic determinantsAngioplasty successPostinfarction anginaAngiographic characteristicsSuccessful angioplastyClinical featuresMyocardial infarctionAnatomic determinantsPrimary successAngioplastyPatientsSuccessful procedureAspirinBeneficial effectsLesionsHigh rateAdditional findingsAngina
1991
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.
Schatz R, Baim D, Leon M, Ellis S, Goldberg S, Hirshfeld J, Cleman M, Cabin H, Walker C, Stagg J. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991, 83: 148-161. PMID: 1984878, DOI: 10.1161/01.cir.83.1.148.Peer-Reviewed Original ResearchConceptsUrgent bypass surgeryBypass surgeryPerioperative complicationsMyocardial infarctionGroup 2Group 1Palmaz-Schatz coronary stentSuccessful elective coronary angioplastyUnderwent cardiac catheterizationElective coronary angioplastyNative coronary arteriesAbsence of symptomsBalloon-expandable stentsClinical thrombosisPerioperative deathsElective angioplastyCardiac catheterizationCoronary angioplastyMajor complicationsMulticenter studyCoronary arteryPatient populationLower incidencePatientsAbrupt closure